Nuzenio

For Pluvicto In

For Pluvicto In news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 03 Aug 2026 15:26:00 GMTFDA expands Pluvicto label, making it available to most metastatic prostate cancer patients - Endpoints News
Mon, 03 Aug 2026 15:07:31 GMTNovartis Pluvicto FDA approval doubles mHSPC patient pool - scanx.trade
Mon, 03 Aug 2026 12:33:04 GMTNovartis' Pluvicto leaps ahead into earlier manifestation of prostate cancer - Fierce Pharma
Sun, 02 Aug 2026 10:06:47 GMTNovartis (SWX:NOVN) Wins FDA Approval For Pluvicto In Earlier Prostate Cancer - Yahoo Finance
Sat, 01 Aug 2026 09:20:02 GMTNovartis wins FDA approval for Pluvicto in earlier-line PSMA+ prostate cancer - Dealroom
Sat, 01 Aug 2026 07:00:00 GMTFDA Expands Approval of Pluvicto in Combination with ARPI for PSMA-Positive mAPMN/S Prostate Cancer - diagnosticimaging.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for For Pluvicto In.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.